This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Nissui Pharmaceutical Past Earnings Performance
Past criteria checks 1/6
Key information
-11.2%
Earnings growth rate
-11.2%
EPS growth rate
| Medical Equipment Industry Growth | 7.8% |
| Revenue growth rate | 6.3% |
| Return on equity | 8.5% |
| Net Margin | 5.9% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Nissui Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 17,181 | 1,011 | 3,283 | 691 |
| 30 Jun 22 | 16,414 | 949 | 3,215 | 691 |
| 31 Mar 22 | 16,657 | 1,146 | 3,003 | 691 |
| 31 Dec 21 | 15,391 | 1,079 | 2,912 | 643 |
| 30 Sep 21 | 15,611 | 1,043 | 2,913 | 643 |
| 30 Jun 21 | 14,438 | 998 | 2,762 | 643 |
| 31 Mar 21 | 12,384 | 648 | 2,761 | 643 |
| 31 Dec 20 | 12,057 | 362 | 3,003 | 695 |
| 30 Sep 20 | 11,652 | 348 | 3,285 | 695 |
| 30 Jun 20 | 12,067 | 441 | 3,612 | 695 |
| 31 Mar 20 | 12,773 | 401 | 3,885 | 695 |
| 31 Dec 19 | 12,633 | 814 | 3,854 | 640 |
| 30 Sep 19 | 12,635 | 868 | 3,846 | 640 |
| 30 Jun 19 | 12,520 | 584 | 3,793 | 640 |
| 31 Mar 19 | 12,549 | 784 | 3,795 | 640 |
| 31 Dec 18 | 12,420 | 766 | 3,606 | 772 |
| 30 Sep 18 | 12,351 | 732 | 3,624 | 772 |
| 30 Jun 18 | 12,159 | 1,146 | 3,589 | 772 |
| 31 Mar 18 | 12,329 | 1,175 | 3,651 | 772 |
| 31 Dec 17 | 12,455 | 1,765 | 3,652 | 866 |
| 30 Sep 17 | 12,738 | 2,222 | 3,661 | 866 |
| 31 Mar 17 | 12,825 | 1,902 | 3,815 | 866 |
Quality Earnings: 4550 has high quality earnings.
Growing Profit Margin: 4550's current net profit margins (5.9%) are lower than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4550's earnings have declined by 11.2% per year over the past 5 years.
Accelerating Growth: 4550's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4550 had negative earnings growth (-3.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.5%).
Return on Equity
High ROE: 4550's Return on Equity (8.5%) is considered low.